Evaluation of Drug–Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor

by Jim J. Xiao, Dorota Nowak, Rodryg Ramlau, Monika Tomaszewska‐Kiecana, Piotr J. Wysocki, Jeff Isaacson, Jeri Beltman, Eileen Nash, Robert Kaczanowski, Gerhard Arold, Simon Watkins
Published 2019-01-01